JP2024525044A5 - - Google Patents
Info
- Publication number
- JP2024525044A5 JP2024525044A5 JP2023580802A JP2023580802A JP2024525044A5 JP 2024525044 A5 JP2024525044 A5 JP 2024525044A5 JP 2023580802 A JP2023580802 A JP 2023580802A JP 2023580802 A JP2023580802 A JP 2023580802A JP 2024525044 A5 JP2024525044 A5 JP 2024525044A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- imidazo
- triazine
- carbonyl
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2109520.3A GB202109520D0 (en) | 2021-07-01 | 2021-07-01 | Therapeutic agents |
| GB2109520.3 | 2021-07-01 | ||
| GBGB2203876.4A GB202203876D0 (en) | 2022-03-21 | 2022-03-21 | Therapeutic agents |
| GB2203876.4 | 2022-03-21 | ||
| PCT/EP2022/068165 WO2023275301A1 (en) | 2021-07-01 | 2022-06-30 | Imidazotriazine derivatives as il-17 modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525044A JP2024525044A (ja) | 2024-07-09 |
| JP2024525044A5 true JP2024525044A5 (https=) | 2025-06-25 |
Family
ID=82493962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580802A Pending JP2024525044A (ja) | 2021-07-01 | 2022-06-30 | Ｉｌ－１７モジュレータとしてのイミダゾトリアジン誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240294534A1 (https=) |
| EP (1) | EP4363421A1 (https=) |
| JP (1) | JP2024525044A (https=) |
| AR (1) | AR126255A1 (https=) |
| TW (1) | TW202317576A (https=) |
| WO (1) | WO2023275301A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| GB202218846D0 (en) | 2022-12-14 | 2023-01-25 | UCB Biopharma SRL | Therapeutic agents |
| GB202218860D0 (en) | 2022-12-14 | 2023-01-25 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2024126249A1 (en) | 2022-12-14 | 2024-06-20 | UCB Biopharma SRL | Imidazotriazine derivatives as il-17 modulators |
| PE20252337A1 (es) * | 2023-02-13 | 2025-10-02 | Dice Alpha Inc | Moduladores de il-17a de imidazotriazina y usos de estos |
| CN121311483A (zh) * | 2023-03-28 | 2026-01-09 | 詹森药业有限公司 | 含内酰胺的咪唑并哒嗪il-17抑制剂化合物 |
| GB202305585D0 (en) | 2023-04-17 | 2023-05-31 | UCB Biopharma SRL | Therapeutic agents |
| GB202305587D0 (en) | 2023-04-17 | 2023-05-31 | UCB Biopharma SRL | Therapeutic agents |
| CN117551093B (zh) * | 2023-11-14 | 2024-06-18 | 山东天锐医药科技有限公司 | 马来酸阿伐曲泊帕起始原料4-(4-氯-2-噻吩基)-2-噻唑胺的制备方法 |
| WO2026012492A1 (en) * | 2024-07-12 | 2026-01-15 | Anew Therapeutics Pte. Ltd. | Heterocyclic compounds as il-17 inhibitors |
| WO2026039168A1 (en) * | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039172A1 (en) * | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039167A1 (en) * | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039170A1 (en) * | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026039171A1 (en) * | 2024-08-12 | 2026-02-19 | Dice Alpha, Inc. | Il-17a inhibitors |
| WO2026073937A1 (en) | 2024-10-02 | 2026-04-09 | UCB Biopharma SRL | Imidazotriazine derivatives as il-17 modulators |
| WO2026073936A1 (en) | 2024-10-02 | 2026-04-09 | UCB Biopharma SRL | Imidazotriazine derivatives as il-17 modulators |
| WO2026073929A1 (en) | 2024-10-02 | 2026-04-09 | UCB Biopharma SRL | Imidazotriazine derivatives as il-17 modulators |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2242504B1 (en) | 2008-01-09 | 2021-07-14 | The Schepens Eye Research Institute, Inc. | Therapeutic compositions for treatment of ocular inflammatory disorders |
| EP2809660B1 (en) | 2012-02-02 | 2016-01-20 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| JP2020516440A (ja) | 2016-11-22 | 2020-06-11 | ヘパトケム，インコーポレイテッド | 光化学デバイス |
| GB201709456D0 (en) | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| US11472794B2 (en) | 2018-01-15 | 2022-10-18 | UCB Biopharma SRL | Fused imidazole derivatives as IL-17 modulators |
| CN110511213B (zh) | 2018-05-22 | 2021-10-19 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| EP3820567A1 (en) | 2018-07-12 | 2021-05-19 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
| GB201820165D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201820166D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| SG11202106444WA (en) | 2018-12-19 | 2021-07-29 | Leo Pharma As | Amino-acid anilides as small molecule modulators of il-17 |
| TWI752400B (zh) | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| US20220162191A1 (en) | 2019-03-08 | 2022-05-26 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB201909191D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909194D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| CN112341439B (zh) | 2019-08-09 | 2022-02-15 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2021027729A1 (zh) | 2019-08-09 | 2021-02-18 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| CN112341441B (zh) | 2019-08-09 | 2022-02-11 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| CN112341446B (zh) | 2019-08-09 | 2022-06-17 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2021098844A1 (zh) | 2019-11-20 | 2021-05-27 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2021170627A1 (en) | 2020-02-25 | 2021-09-02 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| WO2021170631A1 (en) | 2020-02-25 | 2021-09-02 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| WO2021204800A1 (en) | 2020-04-07 | 2021-10-14 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| WO2021204801A1 (en) | 2020-04-07 | 2021-10-14 | UCB Biopharma SRL | Difluorocyclohexyl derivatives as il-17 modulators |
| US20230399328A1 (en) | 2020-11-09 | 2023-12-14 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
| WO2022096411A1 (en) | 2020-11-09 | 2022-05-12 | UCB Biopharma SRL | Dicyclopropylmethyl derivatives as il-17 modulators |
| EP4259631A1 (en) | 2020-12-14 | 2023-10-18 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
-
2022
- 2022-06-28 AR ARP220101681A patent/AR126255A1/es unknown
- 2022-06-29 TW TW111124264A patent/TW202317576A/zh unknown
- 2022-06-30 US US18/572,274 patent/US20240294534A1/en active Pending
- 2022-06-30 JP JP2023580802A patent/JP2024525044A/ja active Pending
- 2022-06-30 EP EP22741247.5A patent/EP4363421A1/en active Pending
- 2022-06-30 WO PCT/EP2022/068165 patent/WO2023275301A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525044A5 (https=) | ||
| JP2023552864A5 (https=) | ||
| USRE49594E1 (en) | Apelin receptor (APJ) agonists and uses thereof | |
| CA2529443A1 (en) | Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors | |
| US9416127B2 (en) | Triazole carboxamides and uses thereof | |
| SG193556A1 (en) | Heterocyclic amine derivatives | |
| JP2002356471A (ja) | 脂肪族含窒素五員環化合物 | |
| US20130172325A1 (en) | Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| HUP0200441A2 (hu) | Tetrahidropiránszármazékok és terápiás szerként való alkalmazásuk és eljárás a vegyületek előállítására | |
| NL1028193C2 (nl) | Farmaceutisch werkzame verbindingen. | |
| JP2021506821A5 (https=) | ||
| WO2016030310A1 (en) | Substituted azetidine derivatives as taar ligands | |
| JP2019521167A5 (https=) | ||
| HRP20241015T1 (hr) | Derivati aminopiridina i njihova uporaba kao selektivnih alk-2 inhibitora | |
| AU2013314388B2 (en) | Pyrazole carboxamide derivatives as TAAR modulators for use in the treatment of several disorders, such as depression, diabetes and Parkinson's disease | |
| RU2014123784A (ru) | Новые производные пирролидина в качестве ингибиторов катепсина | |
| CA2784007C (en) | Pyrrolidine derivatives | |
| EP3137459A1 (en) | Morpholin-pyridine derivatives | |
| RU2587512C2 (ru) | Производные дигидрооксазол-2-амина | |
| CA2449578A1 (en) | Pyrrolidine oxadiazole- and thiadiazole derivatives | |
| EP3008055B1 (en) | Tetrazolone derivatives | |
| RU2013135176A (ru) | Производные пиролидина в качестве антагонистов nk3 | |
| HK1206727A1 (en) | Pyrazine derivatives | |
| WO2019022235A1 (ja) | 円形脱毛症の治療剤又は予防剤 | |
| JP7854780B2 (ja) | 核内受容体に対して活性の化合物 |